{
  "trial_id": "NCT01853748",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "HER2-positive Stage I histologically confirmed invasive carcinoma of the breast",
      "label": "met"
    },
    {
      "criterion": "ER/PR determination is required",
      "label": "unknown"
    },
    {
      "criterion": "Bilateral breast cancers that individually meet eligibility criteria are allowed",
      "label": "met"
    }
  ],
  "exclusion": [
    {
      "criterion": "Pregnant or breastfeeding",
      "label": "not_met"
    },
    {
      "criterion": "Use of potent CYP3A4 inhibitors during the study treatment period",
      "label": "unknown"
    }
  ],
  "notes": "Patient has MDD and is on anti-depressants, but symptoms are still present. She does not drink alcohol or smoke.",
  "_meta": {
    "topic_id": "70",
    "trial_id": "NCT01853748",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}